Mark W. Linder

2.8k citations
64 papers · 2.0k indexed · h-index 24
Topics
Pharmacogenetics and Drug Metabolism (23 papers)Cancer Genomics and Diagnostics (9 papers)Hormonal Regulation and Hypertension (9 papers)

In The Last Decade

Mark W. Linder

64 papers receiving 1.9k citations

Peers

Mark W. Linder
Comparison fields: 5 of 130
  • Pharmacology 902
  • Molecular Biology 394
  • Endocrinology, Diabetes and Metabolism 312
  • Psychiatry and Mental health 300
  • Oncology 268
Replace Shun Higuchi with:
Shun Higuchi Japan
Sarah C. Sim Sweden
Toyoko Hiroi Japan
Lisa L. von Moltke United States
Jan van der Weide Netherlands
Julio Benítez Spain
Vangelis G. Manolopoulos Greece
Pedro Dorado Spain
Maria Gabriella Scordo Italy
S. Ball United States
Mark W. Linder relative to Shun Higuchi Japan Shun Higuchi's profile →
Citations per field
00.5×1.5×
Shun Higuchi · 1×
Citations per year

Countries citing papers authored by Mark W. Linder

Since Specialization
Citations

This map shows the geographic impact of Mark W. Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Linder more than expected).

Fields of papers citing papers by Mark W. Linder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Linder. The network helps show where Mark W. Linder may publish in the future.

Co-authorship network of co-authors of Mark W. Linder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Linder. A scholar is included among the top collaborators of Mark W. Linder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Linder. Mark W. Linder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 4
3 5
4 4
5 84
6 34
7 25
8 32
9 134
10 154
11 89
12 123
13 5
14 76
15 18
16 23
17 11
18 27
19
Differential regulation of hepatic enzymes by polycyclic aromatic hydrocarbons and glucocorticoids
1
20 7

About Mark W. Linder

Mark W. Linder is a scholar working on Pharmacology, Toxicology and Biochemistry, having authored 64 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (23 papers), Cancer Genomics and Diagnostics (9 papers) and Hormonal Regulation and Hypertension (9 papers). The work is most often cited by research in Pharmacology (902 citations), Biochemistry (193 citations) and Psychiatry and Mental health (300 citations). Mark W. Linder has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Roland Valdes, Russell A. Prough, R Valdes, Kristen K. Reynolds, Lori Millner, P E Keck, Nancy Johnson, Bonny L. Bukaveckas, Beate Herpertz‐Dahlmann and Yusheng Zhu. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026